Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Tiny fluorescent probes illuminate protein interactions in living cells

While fluorescence has long been used to tag biological molecules, a new technology developed at Yale allows researchers to use tiny fluorescent probes to rapidly detect and identify protein interactions within living cells while avoiding the biological disruption of existing methods, according to a report in Nature Chemical Biology.

13 Nov 2007

Men who take beta carotene supplements for 15 years or longer may have less cognitive decline

Men who take beta carotene supplements for 15 years or longer may have less cognitive decline, according to a report in the November 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

13 Nov 2007

Omega-3 rich oils lower risk of memory problems, omega-6 rich oils may increase risk

A diet rich in fish, omega-3 oils, fruits and vegetables may lower your risk of dementia and Alzheimer's disease, whereas consuming omega-6 rich oils could increase chances of developing memory problems, according to a study published in the November 13, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

13 Nov 2007

Could a new vaccine be the key to stopping Alzheimer's disease?

A new study from the Oklahoma Medical Research Foundation (OMRF) shows that immunization could offer a way to blunt or even prevent the deadly, memory-robbing disease.

13 Nov 2007

Ageing exhibition reveals scientists' plans for lifelong health

The UK population is rapidly getting older: a predicted 1 in 4 people will be over the age of 65 by 2031. Ensuring that an increasingly ageing population stays healthy and mobile is a challenge for both the Government and the scientific research community.

13 Nov 2007

Diet type linked to cognitive decline and dementia

Research has shown convincing evidence that dietary patterns practiced during adulthood are important contributors to age-related cognitive decline and dementia risk.

6 Nov 2007

False memory syndrome

Duke University Medical Center neuroscientists say the places a memory is processed in the brain may determine how someone can be absolutely certain of a past event that never occurred.

6 Nov 2007

Your Apo E genotype plays part in likelihood of Alzheimer's and heart disease

We all carry the Apo E gene. It plays a key role in the development of Alzheimer's Disease and heart disease, along with a host of chronic ailments.

6 Nov 2007

Prazosin curbs brain damage from post-traumatic stress disorder

A drug used to treat high blood pressure and enlargement of the prostate may protect the brain from damage caused by post-traumatic stress disorder, Alzheimer's disease, depression and schizophrenia.

6 Nov 2007

Maternal link to Alzheimer's disease found

People who have a mother with Alzheimer's disease appear to be at higher risk for getting the disease than those individuals whose fathers are afflicted, according to a new study by NYU School of Medicine researchers.

6 Nov 2007

Cabernet Sauvignon for long-term cognitive health

With National Alzheimer's Awareness Month upon us, attention continues to focus on new approaches to cognitive health in an aging population.

6 Nov 2007

Link between statins and cognitive decline a complex one

Previous explorations of a link between statins, a cholesterol lowering medication, and cognitive decline have produced inconsistent results.

6 Nov 2007

Hypertension or atrial fibrillation linked to Alzheimer's disease progression

Alzheimer's disease (AD) may progress more rapidly in people with high blood pressure or a form of irregular heartbeat, atrial fibrillation, according to results of a Johns Hopkins study published in the Nov. 6, 2007, issue of Neurology.

6 Nov 2007

Children with apoE4 gene show reduced cognitive function

Children who possess a gene known to increase the risk of Alzheimer's disease already show signs of reduced cognitive function, an Oregon Health & Science University study has found.

6 Nov 2007

Practice parameters discuss the evaluation, treatment of circadian rhythm sleep disorders

Practice parameters published in the November 1 issue of the journal SLEEP are a guide to the appropriate assessment and treatment of circadian rhythm sleep disorders (CRSDs).

2 Nov 2007

PET scan distinguishes Alzheimer's from other dementia

A PET scan (positron emission tomography) that measures uptake of sugar in the brain significantly improves the accuracy of diagnosing a type of dementia often mistaken for Alzheimer's disease, a study led by a University of Utah dementia expert has found.

2 Nov 2007

Merck Serono and EPFL announce neuroscience, oncology and drug delivery partnership

Merck Serono, a division of Merck KGaA, and EPFL (Ecole Polytechnique Fédérale de Lausanne), one of the two Swiss Federal Institutes of Technology, announced the signing of a research collaboration agreement in the areas of Neuroscience, Oncology and Drug Delivery. Under this agreement, three Merck Serono-endowed Chairs will be created at EPFL: in neurodegenerative diseases, such as Alzheimer's and Parkinson's; in cancer, in the framework of the Swiss Institute for Experimental Cancer Research (ISREC); and in innovative drug delivery technologies, for instance nanoparticle vaccines.

1 Nov 2007